We have investigated the role of actin polymerization in the defective
polymorphonuclear neutrophil (PMN) chemotaxis of the human newborn, a
nd its regulation by protein kinase C and by phosphatases 1 and 2A. Is
olated PMNs from adult volunteers and healthy term newborns, i.e. umbi
lical cord blood, were studied. Chemotaxis was measured by a modified
micropore filter assay, and actin polymerization was assessed by flow
cytometry. Chemotaxis of newborn PMNs (median 18 mu m, range 9-21 mu m
) was significantly reduced compared with adult PMNs (median 23 mu m,
range 17-34 mu m) (P < 0.001). Coincubation with the protein kinase C
inhibitor bisindolylmaleimide GF109203X, did not significantly alter c
hemotaxis, whereas coincubation with the phosphatase inhibitors calycu
lin A or okadaic acid caused parallel dose-dependent inhibition of che
motaxis in adult and newborn PMNs. Peak actin polymerization was reduc
ed in newborn compared with adult PMNs in response to stimulation with
formyl-methionyl-leucyl-phenylalanine and zymosan-activated serum, bu
t was normal in response to phorbol myristate acetate. Prior incubatio
n for 5 min with bisindolylmaleimide GF109203X, calyculin A, or okadai
c acid caused no significant alterations in the actin polymerization r
esponse to stimulation with formyl-methionyl-leucyl-phenylalanine. We
conclude that: 1) newborn PMNs have reduced actin polymerization in re
sponse to stimulation with chemotactic agents which act via cell surfa
ce receptors, but not with phorbol myristate acetate, which acts direc
tly in the cytoplasm. This suggests that a defect in cell signal trans
duction may be an underlying factor in defective newborn PMN chemotaxi
s. 2) Phosphatase inhibitors strongly inhibit chemotaxis but not actin
polymerization, therefore phosphatases 1 and 2A may be important regu
lators of PMN chemotaxis, but this regulation takes place either at a
point distal to actin polymerization or via another pathway. 3) Simila
r results in adult and newborn PMNs suggest that this is not the site
of the underlying defect in newborn PMN chemotaxis.